Investing.com -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) stock rose 2.4% following the announcement that an abstract on its CRB-701 clinical study has been accepted for presentation at the ...

Holdings announced that an abstract on updated clinical data from its Phase 1/2 clinical study conducted in the ...

Abstracts will be made available on the ESMO website on 13 October 2025 at 00.05 CET. The posters will be available on the Posters & Publications section of Immutep’s website after their presentations ...

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercialising ...

Abstract: This paper presents a novel light balancing technique to compensate uneven illumination based on adaptive gain control, which is specially designed for text images. A segmentation technique ...